Glucolipotoxicity: Fuel Excess and β-Cell Dysfunction
Open accessThe DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Abstract
Glucotoxicity, lipotoxicity, and glucolipotoxicity are secondary phenomena that are proposed to play a role in all forms of type 2 diabetes. The underlying concept is that once the primary pathogenesis of diabetes is established, probably involving both genetic and environmental forces, hyperglycemia and very commonly hyperlipidemia ensue and thereafter exert additional damaging or toxic effects on the beta-cell. In addition to their contribution to the deterioration of beta-cell function after the onset of the disease, elevations of plasma fatty acid levels that often accompany insulin resistance may, as glucose levels begin to rise outside of the normal range, also play a pathogenic role in the early stages of the disease. Because hyperglycemia is a prerequisite for lipotoxicity to occur, the term glucolipotoxicity, rather than lipotoxicity, is more appropriate to describe deleterious effects of lipids on beta-cell function. In vitro and in vivo evidence supporting the concept of glucotoxicity is presented first, as well as a description of the underlying mechanisms with an emphasis on the role of oxidative stress. Second, we discuss the functional manifestations of glucolipotoxicity on insulin secretion, insulin gene expression, and beta-cell death, and the role of glucose in the mechanisms of glucolipotoxicity. Finally, we attempt to define the role of these phenomena in the natural history of beta-cell compensation, decompensation, and failure during the course of type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The basis for this loss is multifactorial, and includes glucolipotoxicity32 and amyloid deposition that result in β-cell apoptosis through oxidative as well as endoplasmic reticulum stress31.”
From Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future (2014) · cites this paper as [32]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls
The Wellcome Trust Case Control Consortium, Management Committee, Burton, P. R., Clayton, D. G., Cardon, L. R., Craddock, N., Deloukas, P., Duncanson, A., Kwiatkowski, D. P., McCarthy, M. I., et al. (2007) · Nature · doi:10.1038/nature05911 · Cited by 9,442
Biochemistry and molecular cell biology of diabetic complications
Brownlee, M. (2001) · Nature · doi:10.1038/414813a · Cited by 9,107
β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes
Butler, A. E., Janson, J., Bonner-Weir, S., Ritzel, R., Rizza, R. A., & Butler, P. C. (2003) · Diabetes · doi:10.2337/diabetes.52.1.102 · Cited by 4,011
A genome-wide association study identifies novel risk loci for type 2 diabetes
Sladek, R., Rocheleau, G., Rung, J., Dina, C., Shen, L., Serre, D., Boutin, P., Vincent, D., Belisle, A., Hadjadj, S., et al. (2007) · Nature · doi:10.1038/nature05616 · Cited by 2,993
Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels
Saxena, R., Voight, B. F., Lyssenko, V., Burtt, N. P., de Bakker, P. I. W., Chen, H., Roix, J. J., Kathiresan, S., Hirschhorn, J. N., Daly, M. J., et al. (2007) · Science · doi:10.1126/science.1142358 · Cited by 2,843
A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants
Scott, L. J., Mohlke, K. L., Bonnycastle, L. L., Willer, C. J., Li, Y., Duren, W. L., Erdos, M. R., Stringham, H. M., Chines, P. S., Jackson, A. U., et al. (2007) · Science · doi:10.1126/science.1142382 · Cited by 2,753
Reactive oxygen species have a causal role in multiple forms of insulin resistance
Houstis, N., Rosen, E. D., & Lander, E. S. (2006) · Nature · doi:10.1038/nature04634 · Cited by 2,525
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
Clément, K., Vaisse, C., Lahlou, N., Cabrol, S., Pelloux, V., Cassuto, D., Gourmelen, M., Dina, C., Chambaz, J., Lacorte, J.-M., et al. (1998) · Nature · doi:10.1038/32911 · Cited by 2,346
Oxidative Stress and Stress-Activated Signaling Pathways: A Unifying Hypothesis of Type 2 Diabetes
Evans, J. L., Goldfine, I. D., Maddux, B. A., & Grodsky, G. M. (2002) · Endocrine Reviews · doi:10.1210/er.2001-0039 · Cited by 2,232
Replication of Genome-Wide Association Signals in UK Samples Reveals Risk Loci for Type 2 Diabetes
Zeggini, E., Weedon, M. N., Lindgren, C. M., Frayling, T. M., Elliott, K. S., Lango, H., Timpson, N. J., Perry, J. R. B., Rayner, N. W., Freathy, R. M., et al. (2007) · Science · doi:10.1126/science.1142364 · Cited by 2,194
Research works printed but not linked: 1
- Shimabukuro M, Higa M, Zhou YT, Wang MY, Newgard CB, Unger RH 1998 Lipoapoptosis in β-cells of obese prediabetic fa/fa rats. Role of serine palmitoyltransferase overexpression. J Biol Chem 273:32487–32490 [DOI] [PubMed] [Google Scholar]
Cited by
Items 401–500 of 999
Merriman, C., & Fu, D. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.010937 · Cited by 38
Yuan, H., Lu, Y., Huang, X., He, Q., Man, Y., Zhou, Y., Wang, S. F., & Li, J. H. (2010) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07911.x · Cited by 36
Evaluation of beta-cell sensitivity to glucose and first-phase insulin secretion in obese dogs
Verkest, K. R., Fleeman, L. M., Rand, J. S., & Morton, J. M. (2011) · American Journal of Veterinary Research · doi:10.2460/ajvr.72.3.357 · Cited by 51
The GTPase Rab37 Participates in the Control of Insulin Exocytosis
Ljubicic, S., Bezzi, P., Brajkovic, S., Nesca, V., Guay, C., Ohbayashi, N., Fukuda, M., Abderrhamani, A., & Regazzi, R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068255 · Cited by 40
“We have previously shown that the expression of Rab3a, Rab27a and Slp4/granuphilin is altered upon exposure of b-cells to conditions mimicking those encountered in Type 2 diabetes [16,26].”
BackgroundThe diabetic β‐cell: hyperstimulated vs. hyperexcited
Nichols, C. G., & Remedi, M. S. (2012) · Diabetes, Obesity and Metabolism · doi:10.1111/j.1463-1326.2012.01655.x · Cited by 36
“Chronic hyperglycaemia also clearly can lead to ‘glucotoxic’ pancreatic β-cell dysfunction, including reduced β-cell mass and loss of insulin content [11].”
BackgroundGosmanov, A. R., Smiley, D. D., Robalino, G., Siqueira, J., Peng, L., Kitabchi, A. E., & Umpierrez, G. E. (2010) · Diabetes Care · doi:10.2337/dc09-1687 · Cited by 39
Glucolipotoxicity-Inhibited miR-299-5p Regulates Pancreatic β-Cell Function and Survival
Huang, Q., You, W., Li, Y., Sun, Y., Zhou, Y., Zhang, Y., Liu, D., Zhan, S., Zhu, Y., & Han, X. (2018) · Diabetes · doi:10.2337/db18-0223 · Cited by 40
“Certain canonical mechanisms, including endoplasmic reticulum (ER) stress, the production of reactive oxygen species, and the induction of proinflammatory cytokines, have been implicated in diabetes biology and are undergoing intense study (5,6).”
BackgroundFutamura, M., Yao, J., Li, X., Bergeron, R., Tran, J., Zycband, E., Woods, J., Zhu, Y.-H., Shao, Q., Maruki-Uchida, H., et al. (2012) · Diabetologia · doi:10.1007/s00125-011-2439-3 · Cited by 37
“This increase in cell death is thought to be a consequence, at least in part, of glucolipotoxicity and associated oxidative stress [20, 21, 43, 44].”
BackgroundKondegowda, N. G., Mozar, A., Chin, C., Otero, P. A., García-Ocaña, A., & Vasavada, R. C. (2012) · Diabetologia · doi:10.1007/s00125-012-2501-9 · Cited by 37
“An increase in beta cell death, probably mediated by GLT, has been observed in several animal models, as well as in patients with type 2 diabetes [1–14, 23].”
BackgroundHou, J. C., Williams, D., Vicogne, J., & Pessin, J. E. (2009) · Endocrinology · doi:10.1210/en.2008-1685 · Cited by 41
Liu, S., Liu, Q., Li, L., Huan, Y., Sun, S., & Shen, Z. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-176 · Cited by 41
JUND regulates pancreatic β cell survival during metabolic stress
Good, A. L., Cannon, C. E., Haemmerle, M. W., Yang, J., Stanescu, D. E., Doliba, N. M., Birnbaum, M. J., & Stoffers, D. A. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.04.007 · Cited by 33
Yang, Y., Kim, J., Park, H., Lee, E., & Yoon, K. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13202 · Cited by 41
Akalestou, E., Suba, K., López–Noriega, L., Georgiadou, E., CHABOSSEAU, P. L., Gallie, A., Wretlind, A., Legido‐Quigley, C., Leclerc, I., Salem, V., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25423-8 · Cited by 34
Zhang, X., Zhang, B., Li, L., Li, X., Zhang, J., & Chen, G. (2022) · Food & Function · doi:10.1039/d2fo00595f · Cited by 39
Recent Pharmacological Options in Type 2 Diabetes and Synergic Mechanism in Cardiovascular Disease
Andreadi, A., Muscoli, S., Tajmir, R., Meloni, M., Muscoli, C., Ilari, S., Mollace, V., Della‐Morte, D., Bellia, A., Daniele, N. D., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021646 · Cited by 39
Peterson, B. S., Campbell, J. E., Ilkayeva, O., Grimsrud, P. A., Hirschey, M. D., & Newgard, C. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.088 · Cited by 40
Serbis, A., Giapros, V. I., Tsamis, K. I., Balomenou, F., Galli‐Τsinopoulou, A., & Siomou, E. C. (2023) · Nutrients · doi:10.3390/nu15092217 · Cited by 46
Liu, J., Guo, L., Yin, F., Zhang, Y., Liu, Z., & Wang, Y. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078315 · Cited by 35
“As reported, glucotoxicity PLOS ONE | www.plosone.org 5 October 2013 | Volume 8 | Issue 10 | e78315 together with lipotoxicity contributes to the deterioration of insulin secretion over the years following the diagnosis of T2DM [32].”
BackgroundInfluentialBoutayeb, W., Lamlili, M. E. N., Boutayeb, A., & Derouich, M. (2014) · Journal of Biomedical Science and Engineering · doi:10.4236/jbise.2014.76035 · Cited by 43
Madec, A., Cassel, R., Dubois, S. G., Ducreux, S., Vial, G., Chauvin, M., Mesnier, A., Chikh, K., Bosco, D., Rieusset, J., et al. (2013) · The FASEB Journal · doi:10.1096/fj.13-234104 · Cited by 38
A 2A adenosine receptors control pancreatic dysfunction in high‐fat‐diet‐induced obesity
Csóka, B., Törő, G., Vindeirinho, J., Varga, Z. V., Koscsó, B., Németh, Z. H., Kókai, E., Antonioli, L., Suleiman, M., Marchetti, P., et al. (2017) · The FASEB Journal · doi:10.1096/fj.201700398r · Cited by 38
“Oxidative (5, 6) and endoplasmic reticulum stress (7, 8), hypoxia (9, 10), as well as exposure to proinflammatory cytokines (11, 12) or high concentration of glucose or fatty acids (known as glucotoxicity/lipotoxicity) (13) are all”
BackgroundDefining lipid mediators of insulin resistance: controversies and challenges
Metcalfe, L. K., Smith, G. C., & Turner, N. A. (2018) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0023 · Cited by 40
Suksangrat, T., Phannasil, P., & Jitrapakdee, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-12668-1_7 · Cited by 35
PrayGod, G., Filteau, S., Range, N. S., Kitilya, B., Kavishe, B. B., Ramaiya, K. L., Jeremiah, K., Rehman, A. M., Changalucha, J. M., Olsen, M. F., et al. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13545 · Cited by 40
Mitochondrial Heterogeneity in Metabolic Diseases
Ngo, J., Osto, C. A., Villalobos, F., & Shirihai, O. S. (2021) · Biology · doi:10.3390/biology10090927 · Cited by 41
Qin, H., Liu, Y., Lu, N., Li, Y., & Sun, C. (2009) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf900534w · Cited by 35
SH2B1 in β-Cells Regulates Glucose Metabolism by Promoting β-Cell Survival and Islet Expansion
Chen, Z., Morris, D. L., Jiang, L., Liu, Y., & Rui, L. (2013) · Diabetes · doi:10.2337/db13-0666 · Cited by 35
Hanefeld, M., Monnier, L., Schnell, O., & Owens, D. R. (2016) · Diabetes Therapy · doi:10.1007/s13300-016-0153-3 · Cited by 37
Reactive Oxygen Species (ROS) in Metabolic Disease—Don’t Shoot the Metabolic Messenger
Lindsay, R. T., & Rhodes, C. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062622 · Cited by 41
“Much is made of oxidative damage during diabetes, and antioxidant approaches are often proposed [80,81].”
Tiam1/Vav2-Rac1 axis: A tug-of-war between islet function and dysfunction
Kowluru, A. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.02.007 · Cited by 32
Nutrient regulation of pancreatic β-cell proliferation
Moullé, V. S., Ghislain, J. J., & Poitout, V. (2017) · Biochimie · doi:10.1016/j.biochi.2017.09.017 · Cited by 35
Self-citationEthnic Similarities and Differences in the Relationship between Beta Cell Mass and Diabetes
Inaishi, J., & Saisho, Y. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm6120113 · Cited by 38
Glucokinase activation or inactivation: Which will lead to the treatment of type 2 diabetes?
Nakamura, A., Omori, K., & Terauchi, Y. (2021) · Diabetes Obesity and Metabolism · doi:10.1111/dom.14459 · Cited by 39
Shah, N. Z., Abdalla, M. A., Deshmukh, H., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188211042145 · Cited by 44
Metabolomic analysis of pancreatic beta cells following exposure to high glucose
Wallace, M., Whelan, H., & Brennan, L. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.10.025 · Cited by 42
Lenin, R. R., Maria, M. S., Agrawal, M., Balasubramanyam, J., Mohan, V., & Balasubramanyam, M. (2012) · Experimental Diabetes Research · doi:10.1155/2012/356487 · Cited by 33
Park, L., Min, D., Kim, H., Park, J., Choi, S., & Park, Y. S. (2011) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.1254 · Cited by 33
“Type 2 diabetes is characterized by insulin resistance and islet β-cell dysfunction, with progressive loss of insulin release being responsible for ever-increasing glucose concentrations [1,2].”
BackgroundHo, M. M., Yoganathan, P., Chu, K. Y., Karunakaran, S., Johnson, J. D., & Clee, S. M. (2013) · BMC Genetics · doi:10.1186/1471-2156-14-10 · Cited by 41
“in fats and sugars is associated with risk of developing type 2 diabetes [34] and many genes that are critical for β-cell function are regulated by glucose [35].”
BackgroundKalwat, M. A., Huang, Z., Wichaidit, C., McGlynn, K., Earnest, S. A., Savoia, C., Dioum, E. M., Schneider, J. W., Hutchison, M. R., & Cobb, M. H. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.5b00993 · Cited by 33
Insulin Use Early in the Course of Type 2 Diabetes Mellitus: The ORIGIN Trial
Hanefeld, M., & Bramlage, P. (2013) · Current Diabetes Reports · doi:10.1007/s11892-013-0366-z · Cited by 36
“A very important finding was that the recovery of β-cell function was improved with a shorter glucotoxic exposure time [26, 27].”
BackgroundBachar-Wikström, E., Ariav, Y., Cerasi, E., Kaiser, Ν., & Leibowitz, G. (2010) · Diabetologia · doi:10.1007/s00125-010-1833-6 · Cited by 34
Dai, Y.-L., Huang, S., & Leng, Y. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.12108 · Cited by 35
Obafemi, T. O., Olasehinde, O. R., Olaoye, O. A., Jaiyesimi, K. F., Adewumi, F. D., Adewale, O. B., & Afolabi, B. A. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00541-0 · Cited by 35
“It has been abundantly proven that exposure ofβcells to chronic hyperglycemia increases ROS production and decreases both insulin content and glucose-stimulated insulin release [55].”
BackgroundLive-cell ATR-FTIR spectroscopy as a novel bioanalytical tool for cell glucose metabolism research
Poonprasartporn, A., & Chan, K. L. A. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119024 · Cited by 36
Chapter 9 Nutrient Modulation of Insulin Secretion
Torres, N., Noriega, L. G., & Tovar, A. R. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00609-2 · Cited by 46
Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c
Chen, K., Jin, P., He, H., Xie, Y., Xie, X., & Mo, Z. (2011) · Journal of Biomedical Science · doi:10.1186/1423-0127-18-57 · Cited by 36
Han, D. G., Yamamoto, Y., Munesue, S., Motoyoshi, S., Saito, H., Win, M. T. T., Watanabe, T., Tsuneyama, K., & Yamamoto, H. (2013) · Genes to Cells · doi:10.1111/gtc.12036 · Cited by 37
Petersen, K. E., Rakipovski, G., Raun, K., & Lykkesfeldt, J. (2016) · Current Diabetes Reviews · doi:10.2174/1573399812666150918150608 · Cited by 37
“Thus, OS is an important factor in glucotoxicity and lipotoxicity as well as the combined glucolipotoxicity [37].”
BackgroundKopprasch, S., Dheban, S., Schuhmann, K., Xu, A., Schulte, K., Simeonovic, C. J., Schwarz, P. E. H., Bornstein, S. R., Shevchenko, A., & Graessler, J. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164173 · Cited by 35
Molecular Mechanism of Pasteurized Akkermansia muciniphila in Alleviating Type 2 Diabetes Symptoms
Niu, H., Zhou, M., Ji, A., Zogona, D., Wu, T., & Xu, X. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c01188 · Cited by 36
The B55α-containing PP2A holoenzyme dephosphorylates FOXO1 in islet β-cells under oxidative stress
Yan, L., Guo, S., Brault, M., Harmon, J., Robertson, R. P., Hamid, R., Stein, R., & Yang, E. (2012) · Biochemical Journal · doi:10.1042/bj20111606 · Cited by 31
Self-citationInflammatory stress in islet β-cells: therapeutic implications for type 2 diabetes?
Lytrivi, M., Igoillo‐Esteve, M., & Cnop, M. (2018) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2018.08.002 · Cited by 30
Antisense Oligonucleotides as Potential Therapeutics for Type 2 Diabetes
Chen, S., Sbuh, N., & Veedu, R. N. (2021) · Nucleic Acid Therapeutics · doi:10.1089/nat.2020.0891 · Cited by 30
“Besides, glucotoxicity, lipo-toxicity, and inflammation caused by hyperglycemia and high FFA concentration impair the pancreatic b cells and finally exhaust their capability to secrete insulin, as a result of cellular dysfunction and apoptosis [50–53].”
Krueger, E. S., Beales, J. L., Russon, K. B., Elison, W. S., Davis, J., Hansen, J. M., Neilson, A. P., Hansen, J. M., & Tessem, J. S. (2021) · Biomolecules · doi:10.3390/biom11121892 · Cited by 33
The Dark Side of Sphingolipids: Searching for Potential Cardiovascular Biomarkers
Pietro, P. D., Izzo, C., Abate, A. C., Iesu, P., Rusciano, M. R., Venturini, E., Visco, V., Sommella, E., Ciccarelli, M., Carrizzo, A., et al. (2023) · Biomolecules · doi:10.3390/biom13010168 · Cited by 35
Wei, Q., Sun, Y., & Zhang, J. (2012) · Peptides · doi:10.1016/j.peptides.2012.06.018 · Cited by 33
Anti microbial and fluorescence activities of L-valinium picrate (LVP) macro and nano crystals
SenthilKannan, K., Krishnaveni, R., Anbuvel, D., Porselvi, V. M., & Ali, H. A. J. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.02.132 · Cited by 30
Flora, G., SenthilKannan, K., Kolanjinathan, M., & Mongiya, J. K. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.05.656 · Cited by 30
Early Insulinization to Prevent Diabetes Progression
Raz, I., & Mosenzon, O. (2013) · Diabetes Care · doi:10.2337/dcs13-2014 · Cited by 35
Protective effect of hydrogen sulfide on pancreatic beta-cells
Okamoto, M., Ishizaki, T., & Kimura, T. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.11.007 · Cited by 30
Ding, Y., Cheng, X., Li, Z.-Q., Wu, S.-J., Yang, Y., Shi, Y., & Le, G. (2017) · RSC Advances · doi:10.1039/c7ra02945d · Cited by 30
Ibitoye, O. B., Olofinsan, K. A., Teralı, K., Ghali, U. M., & Ajiboye, T. O. (2018) · Journal of Food Biochemistry · doi:10.1111/jfbc.12627 · Cited by 40
Sjöblad, S. (2019) · Medical Hypotheses · doi:10.1016/j.mehy.2019.02.027 · Cited by 34
Rahman, M. H., Peng, S., Hu, X., Chen, C., Uddin, S., Quinn, J. M. W., & Moni, M. A. (2019) · IEEE Access · doi:10.1109/access.2019.2960037 · Cited by 31
Kowluru, A. (2020) · Metabolites · doi:10.3390/metabo10120480 · Cited by 34
“Indeed, such an insult would be much more damaging to the islet beta cell, which is inherently ill equipped with adequate antioxidant defense mechanisms [16,20,24,65].”
BackgroundRole of the DNAJ/HSP40 family in the pathogenesis of insulin resistance and type 2 diabetes
Diané, A., Abunada, H. H., Khattab, N., Moin, A. S. M., Butler, A. E., & Dehbi, M. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101313 · Cited by 30
Abaraviciene, S. M., Lundquist, I., & Salehi, A. A. (2008) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8100-8 · Cited by 32
Kim, W., Park, K. J., Kim, G. H., Jeong, E. A., Lee, D. Y., Lee, S. S., Kim, D. J., Roh, G. S., Song, J., Ki, S. H., et al. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.07.028 · Cited by 31
Pathology of Congenital Generalized Lipodystrophy in Agpat2 –/– Mice
Vogel, P., Read, R. W., Hansen, G. M., Wingert, J., DaCosta, C. M., Buhring, L., & Shadoan, M. K. (2010) · Veterinary Pathology · doi:10.1177/0300985810383870 · Cited by 34
Ibitoye, O. B., Uwazie, J. N., & Ajiboye, T. O. (2017) · Journal of Food Biochemistry · doi:10.1111/jfbc.12479 · Cited by 43
Pancreatic islet response to diabetes during pregnancy in rats
Gallego, F. Q., Sinzato, Y. K., Miranda, C. A., Iessi, I. L., Dallaqua, B., Volpato, G. T., Scarano, W. R., Martín, S. S., & Damasceno, D. C. (2018) · Life Sciences · doi:10.1016/j.lfs.2018.10.046 · Cited by 32
Kolanjinathan, M., SenthilKannan, K., Paramasivam, S., Baskaran, P., & Iyanar, M. (2020) · Materials Today Proceedings · doi:10.1016/j.matpr.2020.01.575 · Cited by 29
Intra-Islet PACAP Protects Pancreatic β-Cells Against Glucotoxicity and Lipotoxicity
Nakata, M., Shintani, N., Hashimoto, H., Baba, A., & Yada, T. (2010) · Journal of Molecular Neuroscience · doi:10.1007/s12031-010-9383-4 · Cited by 30
Human Protein Kinases and Obesity
Engin, A. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-48382-5_5 · Cited by 34
Cystic Fibrosis-Related Diabetes (CFRD): Overview of Associated Genetic Factors
IAFUSCO, F., Maione, G., Rosanio, F. M., Mozzillo, E., Franzese, A., & Tinto, N. (2021) · Diagnostics · doi:10.3390/diagnostics11030572 · Cited by 36
“Oxidative stress, a common feature of CF and diabetes [56,57], also seems to be involved in CFRD pathogenesis.”
BackgroundMukhuty, A., Fouzder, C., & Kundu, R. (2021) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2021.111314 · Cited by 31
Shyr, Z. A., Yan, Z., Ustione, A., Egan, E. M., & Remedi, M. S. (2022) · PLoS ONE · doi:10.1371/journal.pone.0258054 · Cited by 36
Peçanha, F. L. M., Jaafar, R., Werneck‐de‐Castro, J. P., Apostolopolou, C.-C., Bhushan, A., & Bernal‐Mizrachi, E. (2022) · Diabetes · doi:10.2337/db21-0908 · Cited by 34
Piro, S., Rabuazzo, A. M., Renis, M., & Purrello, F. (2012) · PubMed · doi:10.3275/7866 · Cited by 35
Xu, Q. R., Chen, S., Deng, L., Feng, L., Huang, L., & Yu, R.-H. (2013) · Brazilian Journal of Medical and Biological Research · doi:10.1590/1414-431x20133163 · Cited by 30
Gu, X., Zhao, H., Sui, Y., Guan, J. Z., Chan, J. C. N., & Tong, P. C. Y. (2010) · Acta Diabetologica · doi:10.1007/s00592-010-0184-6 · Cited by 30
“Insulin deficiency may cause the imbalance of fat metabolism and then led to the high concentrations of free fatty acids in non-adipose compartments, resulting in insulin resistance [20].”
BackgroundGlucocorticoid-Induced Preterm Birth and Neonatal Hyperglycemia Alter Ovine β-Cell Development
Bansal, A., Bloomfield, F. H., Connor, K. L., Dragunow, M., Thorstensen, E. B., Oliver, M. H., Sloboda, D. M., Harding, J. E., & Alsweiler, J. M. (2015) · Endocrinology · doi:10.1210/en.2015-1095 · Cited by 30
Oberhauser, L., Granziera, S., Colom, A., Goujon, A., Lavallard, V., Matile, S., Roux, A., Brun, T., & Maechler, P. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118619 · Cited by 30
Xia, L., Yang, M., Zang, N., Song, J., Chen, J., Hu, H., Wang, K., Xiang, Y., Yang, J., Wang, L., et al. (2024) · International Journal of Nanomedicine · doi:10.2147/ijn.s459077 · Cited by 30
Changing the Concept of Type 2 Diabetes: Beta Cell Workload Hypothesis Revisited
Saisho, Y. (2018) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530318666180821161825 · Cited by 30
Pastore, M., Lori, G., Gentilini, A., Taddei, M. L., Maira, G. D., Campani, C., Recalcati, S., Invernizzi, P., Marra, F., & Raggi, C. (2020) · Cells · doi:10.3390/cells9030596 · Cited by 28
“Most of the cellular functions depend on lipids availability, thus lipid biosynthesis is strictly regulated to avoid lipid toxicity and membrane dysfunction [95,96].”
BackgroundDGAT1 inhibitors protect pancreatic β-cells from palmitic acid-induced apoptosis
Huang, J., Guo, B., Wang, G., Zeng, L.-M., Hu, Y., Wang, T., & Wang, H. (2020) · Acta Pharmacologica Sinica · doi:10.1038/s41401-020-0482-7 · Cited by 33
Suresh, V., & Reddy, A. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-021-00799-y · Cited by 36
Omikorede, O., Cheng, Q., Gorman, T., Chapman, P. J., Yu, A., Smith, D. M., & Herbert, T. P. (2013) · Nutrition and Diabetes · doi:10.1038/nutd.2013.35 · Cited by 29
Pancreas-specific Gsα deficiency has divergent effects on pancreatic α- and β-cell proliferation
Xie, T., Chen, M., & Weinstein, L. S. (2010) · Journal of Endocrinology · doi:10.1677/joe-10-0030 · Cited by 26
Gupta, R. D., Ramachandran, R., Gangadhara, P., Anoop, S., Singh, S. H., Satyaraddi, A., Sathyakumar, S., Asha, H. S., & Thomas, N. (2017) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2017.06.008 · Cited by 30
The role of membrane excitability in pancreatic β-cell glucotoxicity
Shyr, Z. A., Wang, Z., York, N., Nichols, C. G., & Remedi, M. S. (2019) · Scientific Reports · doi:10.1038/s41598-019-43452-8 · Cited by 31
Wagner, R. J., Staiger, H., Ullrich, S., Stefan, N., Fritsche, A., & Häring, H. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.001 · Cited by 27
Pépin, É., Al‐Mass, A., Attané, C., Zhang, K., Lamontagne, J., Lussier, R., Madiraju, S. R. M., Joly, E. C., Ruderman, N. B., SLADEK, R. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153017 · Cited by 30
Zeng, W., Tang, J., Li, H., Xu, H., Lu, H., Peng, H., Lin, C., Gao, R., Lin, S., Lin, K., et al. (2018) · Cellular Signalling · doi:10.1016/j.cellsig.2018.03.013 · Cited by 30
The many lives of Myc in the pancreatic β-cell
Rosselot, C., Baumel-Alterzon, S., Li, Y., Brill, G., Lambertini, L., Katz, L. S., Lu, G., García-Ocaña, A., & Scott, D. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.011149 · Cited by 37
Polydatin mitigates pancreatic β-cell damage through its antioxidant activity
Yousef, A. I., Shawki, H. H., El‐Shahawy, A. A. G., El-Twab, S. M. A., Abdel‐Moneim, A., & Oishi, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111027 · Cited by 27
Nichols, C. G., York, N., & Remedi, M. S. (2022) · Diabetes · doi:10.2337/db21-0755 · Cited by 34
Tang, X., Yan, X., Zhou, H., Huang, G., Niu, X., Jiang, H., Su, H., Yang, X., Li, X., & Zhou, Z. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002075 · Cited by 31
“Excess exposure of beta cells to free fatty acids can decrease beta cell secretory function and cause cell death [25].”
Background
Metadata
- Authors
- Poitout, V., & Robertson, R. P.
- Affiliations
- Pacific Northwest Research Institute (US)
- University of Washington (US)
- Corresponding author
- Poitout, Vincent
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2008-05
- Volume
- 29
- Issue
- 3
- Pages
- 351-366
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC2528858
- OpenAlex
- W2082515526
- Cited by
- 1,092
- References
- 198
- Citations by year
- 2026: 47 · 2025: 55 · 2024: 37 · 2023: 42 · 2022: 38 · 2021: 57 · 2020: 61 · 2019: 50 · 2018: 44 · 2017: 61 · 2016: 79 · 2015: 64 · 2014: 59 · 2013: 81 · 2012: 84
- FWCI
- 81.71
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Canadian Institutes of Health Research (77686)
- National Institute of Diabetes and Digestive and Kidney Diseases (R-01-DK-38325, R01 DK 58096, R01DK038325, R01DK058096)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Endoplasmic Reticulum Stress and Disease
- Keywords
- glucolipotoxicity, glucotoxicity, lipotoxicity, type 2 diabetes, beta-cell dysfunction, hyperglycemia, hyperlipidemia, oxidative stress, insulin secretion, insulin gene expression, beta-cell death, insulin resistance, beta-cell compensation, beta-cell failure
- MeSH terms
- Animals, Diabetes Mellitus, Type 2, Energy Metabolism, Glucose, Humans, Lipid Metabolism, Insulin-Secreting Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.